Skip to content

4Accepted Oct 19, 7:47 PM ET

EXOZymes Inc.: director Lalonde James Joseph received 10,000 shares

EXOZEXOZYMES INC.

Accepted (ET)

7:47 PM

Oct 19, 2026

Filed

Oct 19, 2026

Documents

1

Size

5.7 KB

Summary

EXOZymes Inc.: director Lalonde James Joseph received 10,000 shares

Updated

What happened

  • The filing reports that Lalonde James Joseph, director, received a grant of 10,000 derivative securities on Oct 1, 2026 at $0.00 per share for a total of $0.

Key details

  • Transaction date and type: Oct 1, 2026; grant/other acquisition (code A); price $0.00.
  • Securities after transaction: shares owned after the transaction not reported in this filing.
  • Vesting and expiry (footnote): the option vests in 12 quarterly installments (11 installments of 833 shares and a final installment of 837 shares), beginning on Dec 31, 2026 and ending on Sep 30, 2029; the option expires on Oct 1, 2033; vesting is subject to the reporting person's continued service with the issuer.
  • Filing date: Oct 19, 2026; the form reports the Oct 1, 2026 transaction.

Why it may matter

  • This was a derivative grant (an option award) subject to vesting, not an open-market purchase or sale. A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing